Literature DB >> 15685074

Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment.

Bruno Fuchs1, Robert T Trousdale, Michael G Rock.   

Abstract

To define the importance of the type of surgical treatment, we retrospectively analyzed the survival rate of 60 patients with solitary bony metastasis from renal cell carcinoma. Thirteen patients had wide resection, 20 had local stabilization, and 27 patients had no surgical treatment, but had adjuvant treatment alone. The 1-, 3-, and 5-year survival rates were 83%, 45%, and 23%, respectively. Patients with surgical treatment (wide or intralesional resection) survived longer compared with patients who had no surgical treatment but had adjuvant treatment modalities. However, there was no survival advantage for patients who had a wide resection of the lesion compared with patients who had intralesional resection or intramedullary stabilization alone. Our results indicate that wide surgical excision of a solitary bony metastasis from renal cell carcinoma is not mandatory to improve survival. However, because three of 20 patients (15%) treated with stabilization alone had local disease progression, wide resection of metastatic lesions and stabilization may be necessary to prevent local disease progression and complications.

Entities:  

Mesh:

Year:  2005        PMID: 15685074     DOI: 10.1097/01.blo.0000149820.65137.b4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  28 in total

Review 1.  [Metastasectomy for renal cell cancer].

Authors:  B Brehmer; C Piper; D Pfister; D Porres; A Heidenreich
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.

Authors:  George E Manoukian; Nizar M Tannir; Eric Jonasch; Wei Qiao; Tamara M Haygood; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2011-10-01       Impact factor: 2.872

3.  Metastatic disease of the long bones: a review of the health care burden in a major trauma centre.

Authors:  Michael Kelly; Mitchell Lee; Paul Clarkson; Peter J O'Brien
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

4.  Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis.

Authors:  Seiichi Hosaka; Hirohisa Katagiri; Masashi Niwakawa; Hideyuki Harada; Junji Wasa; Hideki Murata; Mitsuru Takahashi
Journal:  Int J Clin Oncol       Date:  2018-06-29       Impact factor: 3.402

Review 5.  Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?

Authors:  Adrian Husillos Alonso; Manuel Carbonero García; Carmen González Enguita
Journal:  World J Nephrol       Date:  2015-05-06

6.  Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis.

Authors:  Hiroshi Fukushima; Takahiro Hozumi; Takahiro Goto; Keiji Nihei; Katsuyuki Karasawa; Yasukazu Nakanishi; Madoka Kataoka; Ken-Ichi Tobisu; Fumitaka Koga
Journal:  Clin Exp Metastasis       Date:  2016-06-17       Impact factor: 5.150

7.  Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?

Authors:  Satoshi Kato; Satoru Demura; Hideki Murakami; Hiroyuki Tsuchiya
Journal:  Ann Transl Med       Date:  2019-12

8.  Lack of evidence regarding bone metastases of genitourinary cancers: interventions by surgery, radiotherapy, and bone-targeted systemic therapy.

Authors:  Makito Miyake; Takuya Owari; Kiyohide Fujimoto
Journal:  Ann Transl Med       Date:  2019-07

9.  Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.

Authors:  Attila Szendroi; Elek Dinya; Magdolna Kardos; A Marcel Szász; Zsuzsanna Németh; Katalin Ats; János Kiss; Imre Antal; Imre Romics; Miklós Szendroi
Journal:  Pathol Oncol Res       Date:  2009-07-29       Impact factor: 3.201

Review 10.  [Operative therapy of spinal metastases from urological tumors].

Authors:  R H Richter; M Hammon; M Uder; J Huber; P J Goebell; F Kunath; B Wullich; B Keck
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.